封面
市场调查报告书
商品编码
1918136

治疗床市场 - 2026-2031 年预测

Therapeutic Bed Market - Forecast from 2026 to 2031

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 152 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计治疗床市场将从 2025 年的 53.61 亿美元成长到 2031 年的 69.58 亿美元,复合年增长率为 4.44%。

慢性病盛行率上升、人口老化以及人们对睡眠障碍的认识不断提高,推动了治疗床市场强劲成长。这些特殊病床旨在促进特定疾病或身体障碍患者的健康并改善其睡眠质量,并提供可调节功能以满足不同患者的需求。治疗床的许多好处,加上慢性病负担加重、人口结构变化、人们对睡眠障碍的认识不断提高以及对预防压疮的日益重视,共同推动了市场扩张。

主要市场驱动因素

治疗床的优势

治疗床为患有各种疾病的患者、老年人和需要特殊护理的人士提供许多益处。这些床的设计旨在提供最佳舒适度,让患者能够更好地休息和睡眠。其可调节性,包括高度调节和个人化定位,使患者能够找到最适合自身需求的舒适支撑姿势。治疗床适用于多种疾病:呼吸系统疾病患者可受益于头部抬高,而循环系统疾病患者则可受益于腿部抬高。这种多功能性使得治疗床在各种临床和居家照护环境中都发挥着重要作用。

慢性病盛行率

随着糖尿病、心血管疾病和呼吸系统疾病等慢性病患者数量的增加,需要特殊医疗照护的患者群体日益壮大,推动了治疗床市场的发展。癌症是全球首要死因,2020年约有1,000万人死于癌症,约占全球死亡总数的六分之一。全球约有4.22亿人患有糖尿病,2000年至2019年间盛行率增加了3%。对于从医院过渡到居家照护的慢性疾病患者,治疗床能够提供持续的护理,有效控制症状,并提高患者在院外的生活品质。

人口结构方面的必然要求

老年人通常需要更专业的照顾和帮助,而治疗床对于为他们提供舒适安全的睡眠环境至关重要。随着世界人口老化,老年人医疗保健服务和产品的需求日益增长。预计到2050年,60岁及以上人口的比例将从2015年的12%上升至22%,这意味着老年人口将显着增长。预期寿命也显着提高,从2000年的66.8岁提高到2019年的73.3岁。这种人口结构变化导致对治疗床的需求持续增长,因为寿命延长与慢性病患病率升高有关,从而增加了对专业睡眠环境和护理解决方案的需求。

对睡眠障碍的认识

人们对充足睡眠及其对整体健康影响的认识不断提高,预计将推动治疗床市场的扩张。各种项目和宣传活动正在进行,以支持这一趋势。美国国家睡眠基金会每年三月都会举办“全国睡眠意识週”,提醒人们睡眠与健康之间的重要连结。该基金会也出版《睡眠健康杂誌》,探讨睡眠与健康的社会科学观点。学术机构开设的课程旨在帮助学生全面且实用地了解睡眠障碍,涵盖其潜在机制、临床症状和有效的管理策略。人们对睡眠在整体健康中所扮演角色的认识不断提高,正在推动对优质睡眠解决方案的需求。

预防压疮

压疮(褥疮)是行动不便患者面临的一大难题。配备减压功能的治疗床和专用床垫对于预防这些疼痛且可能危及生命的压疮至关重要。在美国,每年约有250万人罹患压疮。如此沉重的压疮负担预计将推动治疗床市场的成长。美国护理学会已实施围手术全期疮预防计划,旨在透过积极的预防措施降低压疮的发生率。由于临床疗效和成本方面的考量,医疗保健系统日益重视压疮预防,治疗床的普及速度正在加快。

市场约束

儘管治疗床市场呈现成长态势,但也面临诸多挑战。与传统病床相比,治疗床高成本相对较高,这对小规模医疗机构而言构成了一大障碍。部分治疗床,尤其是配备先进功能或电子控制系统的,需要更复杂的安装和定期维护,从而增加医疗机构的成本和时间负担。此外,某些患者有特殊需求,传统设计无法完全满足,而缺乏高级自订功能可能会限制其在某些人群中的应用。

区域和近期趋势

由于慢性病发病率上升、人口老化、技术进步、人们对睡眠障碍的认识不断提高以及政府的支持,预计北美在预测期内将占据显着的市场份额。 2021年,美国疾病管制与预防中心(CDC)向美国睡眠医学会授予了一项为期三年的津贴,用于推广睡眠呼吸中止症的教育和宣传。过去十年糖尿病盛行率的显着增长(影响了美国约3,730万人)也进一步推动了市场成长。

2023 年 2 月,史赛克公司推出了 SmartMedic 平台,旨在增强医院现有的ICU病床能力,这反映了重症监护病床技术的持续创新。

治疗床市场持续发展,受到人口趋势、慢性病负担以及人们对睡眠品质在健康结果中作用的认识不断提高的推动。

本报告的主要优势:

  • 深入分析:取得以客户群、政府政策和社会经济因素、消费者偏好、垂直产业和其他细分市场为重点的深入市场洞察,涵盖主要地区和新兴地区。
  • 竞争格局:了解主要企业采取的策略倡议,并了解透过正确的策略实现市场渗透的潜力。
  • 市场驱动因素与未来趋势:探索动态因素和关键市场趋势,以及它们将如何塑造未来的市场发展。
  • 可执行的建议:利用洞察力为策略决策提供讯息,从而在动态环境中开拓新的业务管道和收入来源。
  • 受众范围广:对新兴企业、研究机构、顾问公司、中小企业和大型企业都有益处且经济高效。

它是用来做什么的?

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范及其影响、新产品开发、竞争影响

分析范围

  • 历史资料(2021-2025 年)和预测资料(2026-2031 年)
  • 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
  • 竞争对手定位、策略和市场占有率分析
  • 按业务板块和地区(国家)分類的收入成长和预测分析
  • 公司概况(策略、产品、财务资讯、关键趋势等)

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 分析范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策和法规
  • 策略建议

第四章 技术展望

第五章 按产品分類的治疗床市场

  • 介绍
  • 临床床
    • 普通床
    • 加护病房床位
    • 儿童床
    • 产床
    • 其他的
  • 普通床
  • 配件

第六章 依应用分類的治疗床市场

  • 介绍
  • 急诊护理病床
  • 重症加护病床
  • 长期照护床位

第七章 按最终用户分類的治疗床市场

  • 介绍
  • 医院和诊所
  • 生殖医学中心
  • 其他的

第八章:各地区的治疗床市场

  • 介绍
  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第九章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 企业合併、协议、商业合作
  • 竞争对手仪錶板

第十章:公司简介

  • Hill Rom, Inc.(Baxter)
  • Stryker Corporation
  • Invacare Corporation
  • Medline Industries
  • Medical Depot Inc.
  • GF Health Products, Inc.
  • Arjo
  • Amico Group of Companies
  • Bakare Beds Ltd.

第十一章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 分析方法
  • 简称
简介目录
Product Code: KSI061615972

The therapeutic bed Market, with a 4.44% CAGR, is forecasted to expand from USD 5.361 billion in 2025 to USD 6.958 billion in 2031.

The therapeutic bed market is experiencing robust growth driven by rising chronic disease prevalence, aging populations, and increasing awareness of sleep disorders. These specialized beds-designed to provide health benefits and improve sleep quality for individuals with specific medical conditions or physical challenges-offer adjustable features addressing diverse patient needs. Various therapeutic bed advantages, combined with growing chronic disease burden, demographic shifts, sleep disorder awareness, and emphasis on pressure ulcer prevention, are propelling market expansion.

Primary Market Drivers

Therapeutic Bed Benefits

Therapeutic beds offer a wide range of benefits for patients with various medical conditions, elderly individuals, and those requiring specialized care. These beds are designed to provide optimal comfort, allowing patients to rest and sleep more comfortably. Adjustable features-including height adjustments and customizable positioning-enable patients to find the most comfortable and supportive positions for their specific needs. Therapeutic beds cater to various medical conditions: patients with respiratory issues may benefit from elevating the head to improve breathing, while individuals with circulation problems may benefit from elevating the feet. This versatility makes therapeutic beds valuable across diverse clinical scenarios and home care settings.

Chronic Disease Prevalence

Rising chronic disease prevalence-including diabetes, cardiovascular diseases, and respiratory disorders-has led to larger numbers of patients with specific medical needs, propelling the therapeutic bed market. Roughly 10 million deaths, or approximately one in six deaths, were caused by cancer in 2020, making it the leading cause of death globally. Around 422 million people are living worldwide with diabetes, with prevalence rates increasing by 3% between 2000 and 2019. For patients with chronic conditions transitioning from hospitals to homecare settings, therapeutic beds provide continuity of care, enabling effective symptom management and improved quality of life outside institutional settings.

Demographic Imperatives

Older adults often require more specialized care and support, making therapeutic beds crucial in providing comfortable and safe environments for aging individuals. As global populations continue aging, there is higher demand for healthcare services and products catering to elderly populations. The percentage of people aged over 60 years globally is expected to rise from 12% in 2015 to 22% by 2050, indicating substantial increases in elderly populations. Life expectancy has seen significant increases, rising from 66.8 years in 2000 to 73.3 years in 2019. This demographic evolution creates sustained demand for therapeutic beds as longer lifespans often correlate with increased chronic condition prevalence requiring specialized sleeping and care solutions.

Sleep Disorder Awareness

Growing awareness of restful sleep's value and its effects on general health is expected to bolster the therapeutic bed market. Various programs and awareness initiatives support this trend. National Sleep Awareness Week is organized annually in March by the National Sleep Foundation to reemphasize the important connection between sleep and health. The National Sleep Foundation also publishes Sleep Health Journal to explore social science perspectives on sleep and health. Educational institutions offer courses providing thorough and practical understanding of sleep disorders, covering underlying mechanisms, clinical manifestations, and effective management strategies. This growing recognition of sleep's role in overall health outcomes drives demand for solutions supporting quality sleep.

Pressure Ulcer Prevention

Pressure ulcers (bedsores) represent significant concerns for immobile patients. Therapeutic beds with pressure-relieving features and specialized mattresses are critical in preventing development of these painful and potentially dangerous sores. Approximately 2.5 million U.S. people develop pressure injuries annually. This substantial pressure ulcer burden is expected to aid therapeutic bed market growth. The Perioperative Pressure Ulcer Program is being run by the American Academy of Nursing to reduce pressure ulcer incidence through aggressive prevention methods. As healthcare systems increasingly prioritize pressure ulcer prevention due to clinical outcomes and cost considerations, therapeutic bed adoption accelerates.

Market Constraints

Despite positive growth trajectories, the therapeutic bed market faces challenges. Therapeutic beds can be relatively expensive compared to traditional beds, with high costs representing significant barriers for smaller healthcare facilities. Some therapeutic beds, particularly those with advanced features and electronic controls, may require more complex setup and regular maintenance, leading to additional costs and time investments for healthcare facilities. Additionally, certain patients can have particular requirements not completely met by conventional designs, with absence of highly customizable features potentially hampering applicability for some individuals.

Regional Dynamics and Recent Developments

North America is expected to hold significant market share during the forecast period, supported by increasing chronic diseases, rising elderly populations, technological advancements, growing sleep disorder awareness, and government support. The CDC awarded a 3-year grant in 2021 to the American Academy of Sleep Medicine to expand sleep apnea education and awareness. Diabetes prevalence increased significantly in the past decade, affecting around 37.3 million U.S. population, further driving market growth.

In February 2023, Stryker launched the SmartMedic platform enhancing existing ICU bed capabilities at hospitals, demonstrating ongoing innovation in therapeutic bed technology focused on critical care applications.

The therapeutic bed market continues evolving, driven by demographic trends, chronic disease burden, and growing recognition of sleep quality's role in health outcomes.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Therapeutic Bed Market Segmentation

  • By Product
  • Clinical Beds
  • Regular Beds
  • ICU Beds
  • Pediatric Beds
  • Birthing Beds
  • Others
  • Household Beds
  • Accessories
  • By Application
  • Acute Care Beds
  • Critical Care Beds
  • Long-term Beds
  • By End-User
  • Hospital & Clinics
  • Reproductive Care Centers
  • Others
  • By Geography
  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. THERAPEUTIC BED MARKET BY PRODUCT

  • 5.1. Introduction
  • 5.2. Clinical Beds
    • 5.2.1. Regular Beds
    • 5.2.2. ICU Beds
    • 5.2.3. Pediatric Beds
    • 5.2.4. Birthing Beds
    • 5.2.5. Others
  • 5.3. Household Beds
  • 5.4. Accessories

6. THERAPEUTIC BED MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Acute Care Beds
  • 6.3. Critical Care Beds
  • 6.4. Long-term Beds

7. THERAPEUTIC BED MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospital & Clinics
  • 7.3. Reproductive Care Centers
  • 7.4. Others

8. THERAPEUTIC BED MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Hill Rom, Inc. (Baxter)
  • 10.2. Stryker Corporation
  • 10.3. Invacare Corporation
  • 10.4. Medline Industries
  • 10.5. Medical Depot Inc.
  • 10.6. GF Health Products, Inc.
  • 10.7. Arjo
  • 10.8. Amico Group of Companies
  • 10.9. Bakare Beds Ltd.

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations